Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CTLA4 gene polymorphism and autoimmunity.

Stephen C L Gough1, Lucy S K Walker, David M Sansom

  • 1Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham, Birmingham B9 5SS, UK. s.c.gough@bham.ac.uk

Immunological Reviews
|March 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An imbalance between CD80 and CD86 levels and CD4 regulatory T cell number and transendocytosis function exists in the liver in autoimmune hepatitis.

Clinical and experimental immunology·2026
Same author

Immune dysregulation from a novel CTLA-4 haploinsufficiency variant.

Journal of human immunity·2026
Same author

CD28 and TCR differentially impact naïve and memory T cell responses.

Discovery immunology·2025
Same author

How do autoimmune CD4<sup>+</sup> T cells handle exhaustion?

Trends in immunology·2024
Same author

CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner.

Nature communications·2024
Same author

An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy.

Cell reports·2024
Same journal

Diversity, Equality, and Inclusion in the naïve T Cell Receptor Repertoire.

Immunological reviews·2026
Same journal

Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure.

Immunological reviews·2026
Same journal

The T Cell Receptor: Molecular Sensor, Therapeutic Mediator and Probabilistic Driver of Adaptive Immunity.

Immunological reviews·2026
Same journal

Tissue-Resident Memory T Cells in the Heart: An Emerging Role in Chronic Inflammation.

Immunological reviews·2026
Same journal

Rethinking Immunity in Tissues: The Biology of Tertiary Lymphoid Structures.

Immunological reviews·2026
Same journal

Inflammation-Driven Lymphoid Structures: Organization, Function, and Clinical Impact Across Autoimmunity, Cancer, and Checkpoint Toxicity.

Immunological reviews·2026
See all related articles

Cytotoxic T-lymphocyte antigen-4 (CTLA4) inhibits T-cell responses, making it a key factor in autoimmunity. Research links CTLA4 gene variations to disease susceptibility and explores its inhibitory mechanisms.

Area of Science:

  • Immunology
  • Genetics
  • Autoimmunity

Background:

  • CD28 and CTLA4 are critical T-cell receptors with opposing functions.
  • CD28 stimulates T-cell activity, while CTLA4 inhibits it.
  • CTLA4's inhibitory role suggests its involvement in autoimmune diseases.

Purpose of the Study:

  • To review recent advancements in understanding CTLA4 polymorphisms.
  • To explore the relationship between CTLA4 gene variations and disease susceptibility.
  • To discuss potential mechanisms of CTLA4 in inhibiting autoimmunity.

Main Methods:

  • Literature review of studies on CTLA4 polymorphisms and autoimmunity.
  • Analysis of research on the functional mechanisms of CTLA4.
  • Synthesis of current knowledge on CTLA4's role in immune regulation.

Related Experiment Videos

Main Results:

  • Several studies suggest associations between CTLA4 polymorphisms and autoimmune disease susceptibility.
  • CTLA4 is recognized as a significant candidate gene for autoimmunity.
  • Ongoing research aims to elucidate the precise mechanisms by which CTLA4 influences autoimmune conditions.

Conclusions:

  • CTLA4 gene variations are implicated in autoimmune disease risk.
  • Understanding CTLA4's inhibitory function is crucial for autoimmune research.
  • Further investigation into CTLA4 polymorphisms and mechanisms is warranted.